两个肝细胞癌病灶对99m锝-亚氨基二乙酸盐和99m锝-半乳糖人血清白蛋白摄取不一致。

Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions.

作者信息

Tanabe Y, Hashimoto M, Ohuchi Y, Kodama F, Ogawa T

机构信息

Department of Radiology, Faculty of Medicine, Tottori University, Yonago, Japan.

出版信息

Ann Nucl Med. 2000 Dec;14(6):485-8. doi: 10.1007/BF02988296.

DOI:10.1007/BF02988296

PMID:11210102

Abstract

Tc-99m PMT and Tc-99m GSA can be taken up by hepatocellular carcinoma (HCC), but there has been no report concerning HCC showing accumulation of both of Tc-99m PMT and Tc-99m GSA. In this paper we describe a case of two simultaneously developed HCCs, one of which took up both tracers but the other took up neither of them.

摘要

锝-99m 吡哆醛-5-甲基色氨酸（Tc-99m PMT）和锝-99m 半乳糖人血清白蛋白（Tc-99m GSA）可被肝细胞癌（HCC）摄取，但尚无关于HCC同时显示Tc-99m PMT和Tc-99m GSA两者均有摄取的报道。在本文中，我们描述了一例同时发生的两个HCC病例，其中一个摄取了两种示踪剂，而另一个则均未摄取。